-
ATS 2026 Orlando Sessions Examine Recent Insights and Unique Challenges for Treating COPD
on
Recent reports show that chronic obstructive pulmonary disease (COPD) was the fifth leading cause of death in the United States in 2023, with 141,733 deaths related to the disease during that year. Additionally, treatments for the disease incur annual medical costs of approximately $24 billion for adults aged 45 and older. Spyridon Fortis, MD, PhD, MSc, spoke with ATS Conference News about the current landscape of COPD therapies, previewing topics that will be explored throughout ATS 2026 Orlando programming.
More #ATS2026 News
-
ATS Diversity Forum Speaker to Explore Resilience in a Time of Challenge
on
The annual ATS Diversity Forum celebrates diversity in pulmonary, critical care, and sleep medicine and offers accessible career insights and networking opportunities in a welcoming environment. This year’s featured speaker is Jennifer L. Taylor, MD, MSCS, ATSF, who will explore the theme, “Resilience in a Time of Challenge.” This year’s event is scheduled for 11:45…
-
Women’s Forum Panel Highlights Real-World Strategies for Career and Professional Growth
on
The Women’s Forum at the ATS 2026 International Conference is introducing a new twist: For the first time, the Forum will feature a talk-show format with five distinguished panelists. The discussion will focus on numerous crucial topics, offering practical perspectives to spur personal and professional growth. The event will be held from 11:45 a.m. –…